Form: 3

Initial statement of beneficial ownership of securities

September 14, 2022

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Batchelor Ann-Louise

(Last) (First) (Middle)
1489 WEST WARM SPRINGS ROAD,
SUITE 110

(Street)
HENDERSON NV 89014

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/12/2022
3. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Group Chief Marketing Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 18,908(1) D
Common Stock 29,406 I By Spouse
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) 04/15/2017 04/15/2026 Common Stock 50,000 4 I By Spouse
Stock Option (Right to Buy) 01/23/2019 01/23/2028 Common Stock 31,126 4 D
Stock Option (Right to Buy) 02/11/2020 02/11/2025 Common Stock 40,000 3.25 I By Spouse
Stock Option (Right to Buy) 09/21/2021 03/30/2027 Common Stock 50,000 5 D
Stock Option (Right to Buy) 09/21/2021 01/23/2028 Common Stock 18,874 4.38 D
Stock Option (Right to Buy) 09/21/2021 04/13/2030 Common Stock 55,000 3.6 D
Stock Option (Right to Buy) 08/03/2022 08/03/2031 Common Stock 22,229 3.4 D
Stock Option (Right to Buy) 08/03/2023 08/03/2031 Common Stock 22,228 3.4 D
Explanation of Responses:
1. Includes 12,062 restricted stock units subject to vesting on August 3, 2023. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Remarks:
/s/ Ann-Louise Batchelor 09/14/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.